InvestorsHub Logo
Followers 4
Posts 269
Boards Moderated 0
Alias Born 03/28/2018

Re: SPORT19 post# 5624

Thursday, 03/29/2018 3:15:14 PM

Thursday, March 29, 2018 3:15:14 PM

Post# of 7901
You’re quite welcome. It’s a shame to see investors get scammed but that’s exactly what is happening and Todd Pope knows it.

The vast majority of the general public has no idea of what happens inside of surgical services. The OR is off limits to 90% of the hospital. What happens inside is a mystery and it’s quite hard to understand the dynamics.

Even those that work inside of the OR are in the dark when it comes to Robotic Surgery and Robotic Assisted Surgical Device’s (RASD).

With that said, people seem to think that a 10 year old nonviable RASD is somehow “the latest and greatest” just because a salesman says it is.

My advice to anyone thinking of investing in TRXC has always been, Don’t do it, there are “too many moving parts” for you to understand in order to make a wise investment decision.

I called the Surgibot rejection 3 days before the FDA rejected it, I actually made some money for friends who bailed in the 5’s. I also called the FDA rejection of ALF, and guess what? I was right. I was always my contention that the huge 4 arm footprint was not only impractical, but dangerous. The FDA agreed and that is exactly why Alf is only available in the United States with 3 arms. The FDA either denied or told pope in advance that 4 arms would not be approved. So he is forging ahead with a 3 arm behemoth without warning investors.
That was a death blow as there is absolutely no way Alf is able to provide the basic dissection technique of counter traction on its own.

The surgeon is now at the mercy of an assistant, and patients are going to pay for it.

Shame on you Pope.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y